Dirajlal-Fargo S - Search Results

1

Lipidome association with vascular disease and inflammation in HIV+ Ugandan children.

Dirajlal-Fargo S, Sattar A, Yu J, Albar Z, Chaves FC, Riedl K, Kityo C, Bowman E, McComsey GA, Funderburg N. Dirajlal-Fargo S, et al. AIDS. 2021 Aug 1;35(10):1615-1623. doi: 10.1097/QAD.0000000000002923. AIDS. 2021. PMID: 33878042 Free PMC article.

2

Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.

Dirajlal-Fargo S, Kinley B, Jiang Y, Longenecker CT, Hileman CO, Debanne S, McComsey GA. Dirajlal-Fargo S, et al. AIDS. 2015 Jan 28;29(3):313-21. doi: 10.1097/QAD.0000000000000547. AIDS. 2015. PMID: 25686680 Free PMC article. Clinical Trial.

3

Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults.

Hileman CO, Dirajlal-Fargo S, Lam SK, Kumar J, Lacher C, Combs GF Jr, McComsey GA. Hileman CO, et al. J Nutr. 2015 Oct;145(10):2293-9. doi: 10.3945/jn.115.214577. Epub 2015 Aug 12. J Nutr. 2015. PMID: 26269240 Free PMC article. Clinical Trial.

4

The effect of physical activity on cardiometabolic health and inflammation in treated HIV infection.

Dirajlal-Fargo S, Webel AR, Longenecker CT, Kinley B, Labbato D, Sattar A, McComsey GA. Dirajlal-Fargo S, et al. Antivir Ther. 2016;21(3):237-45. doi: 10.3851/IMP2998. Epub 2015 Oct 12. Antivir Ther. 2016. PMID: 26455521 Free PMC article. Clinical Trial.

5

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.

Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. Dirajlal-Fargo S, et al. Open Forum Infect Dis. 2016 Aug 29;3(3):ofw174. doi: 10.1093/ofid/ofw174. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27704026 Free PMC article.

6

Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.

Dirajlal-Fargo S, Alam K, Sattar A, Kulkarni M, Funderburg N, Wilson WH, McComsey GA. Dirajlal-Fargo S, et al. AIDS. 2017 Feb 20;31(4):533-537. doi: 10.1097/QAD.0000000000001363. AIDS. 2017. PMID: 27922857 Free PMC article.

7

Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial.

Dirajlal-Fargo S, Musiime V, Cook A, Mirembe G, Kenny J, Jiang Y, Debanne S, Klein N, McComsey GA. Dirajlal-Fargo S, et al. Pediatr Infect Dis J. 2017 Aug;36(8):761-767. doi: 10.1097/INF.0000000000001544. Pediatr Infect Dis J. 2017. PMID: 28067719 Free PMC article. Clinical Trial.

8

HIV-positive youth who are perinatally infected have impaired endothelial function.

Dirajlal-Fargo S, Sattar A, Kulkarni M, Bowman E, Funderburg N, McComsey GA. Dirajlal-Fargo S, et al. AIDS. 2017 Sep 10;31(14):1917-1924. doi: 10.1097/QAD.0000000000001556. AIDS. 2017. PMID: 28590332 Free PMC article.

9

Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.

Dirajlal-Fargo S, Sattar A, Kulkarni M, Funderburg N, McComsey GA. Dirajlal-Fargo S, et al. HIV Clin Trials. 2017 Jul;18(4):156-163. doi: 10.1080/15284336.2017.1366001. Epub 2017 Aug 22. HIV Clin Trials. 2017. PMID: 28828963 Free PMC article.

10

Effect of statin on arginine metabolites in treated HIV-infection.

Dirajlal-Fargo S, El Kamari V, Sattar A, Alam K, Funderburg N, Labbato D, Pirro L, Longenecker CT, Wilson WH, McComsey GA. Dirajlal-Fargo S, et al. Atherosclerosis. 2017 Nov;266:74-80. doi: 10.1016/j.atherosclerosis.2017.09.030. Epub 2017 Sep 28. Atherosclerosis. 2017. PMID: 28992467 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters